Longevity Health Holdings, Inc. Common Stock
XAGE
XAGE was delisted on the 11th of September, 2025.
40 hedge funds and large institutions have $125M invested in Longevity Health Holdings, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
18% more funds holding
Funds holding: 34 → 40 (+6)
8% more capital invested
Capital invested by funds: $116M → $125M (+$9.63M)
0.16% more ownership
Funds ownership: 2.54% → 2.7% (+0.16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$3.87M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.57M |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$1.69M |
| 4 |
HCM
Highbridge Capital Management
New York
|
+$773K |
| 5 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$729K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$3.48M |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$227K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$214K |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$117K |
XAGE Hedge Fund Activity: Q3 2022 in Review
40 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Common Stock (XAGE) for Q3 2022, worth a combined $125M — up 8.3% from $116M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new XAGE positions and 1 closed out — a net gain of 7 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $3.87M. The largest seller was AQR Arbitrage, cutting an estimated $3.48M.
- 40 institutional investors held Longevity Health Holdings, Inc. Common Stock (XAGE) as of Q3 2022, up from 34 in Q2 2022.
- Funds reported $125M of Longevity Health Holdings, Inc. Common Stock stock for Q3 2022, up 8.3% quarter-over-quarter.
- 8 funds opened new Longevity Health Holdings, Inc. Common Stock positions in Q3 2022 and 1 closed out, a net change of +7 holders.
- The largest Longevity Health Holdings, Inc. Common Stock buyer in Q3 2022 was Goldman Sachs, an estimated $3.87M added.
- The largest Longevity Health Holdings, Inc. Common Stock seller in Q3 2022 was AQR Arbitrage, an estimated $3.48M sold.
Based on aggregated 13F filings for Q3 2022.